Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rockwell Medical

1.17
-0.0200-1.68%
Post-market: 1.170.00000.00%16:09 EDT
Volume:126.77K
Turnover:147.36K
Market Cap:39.85M
PE:-46.47
High:1.20
Open:1.18
Low:1.14
Close:1.19
Loading ...

Company Profile

Company Name:
Rockwell Medical
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
244
Office Location:
30142 South Wixom road,Wixom,Michigan,United States
Zip Code:
48393
Fax:
248 960 9119
Introduction:
Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Directors

Name
Position
John P. McLaughlin
Chairman of the Board
Russell H. Ellison
President and Chief Executive Officer, Director
Allen R. Nissenson
Director
Andrea Heslin Smiley
Director
John G. Cooper
Director
Mark H. Ravich
Director
Robert S. Radie
Director

Shareholders

Name
Position
Russell H. Ellison
President and Chief Executive Officer, Director
Russell Skibsted
Chief Financial Officer
Marc Hoffman
Chief Medical Officer
Paul E. McGarry
Vice President, Corporate Controller and Principal Accounting Officer
Raymond D. Pratt
Chief Development Officer